Literature DB >> 286319

DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

M Wigler, A Pellicer, S Silverstein, R Axel, G Urlaub, L Chasin.   

Abstract

In this report, we demonstrate the feasibility of transforming mouse cells deficient in adenine phosphoribosyltransferase (aprt; AMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.7) to the aprt+ phenotype by means of DNA-mediated gene transfer. Transformation was effected by using unfractionated high molecular weight genomic DNA from Chinese hamster, human, and mouse cells and restriction endonuclease-digested DNA from rabbit liver. The transformation frequency observed was between 1 and 10 colonies per 10(6) cells per 20 microgram of donor DNA. Transformants displayed enzymatic activity that was donor derived as demonstrated by isoelectric focusing of cytoplasmic extracts. These transformants fall into two classes: those that are phenotypically stable when grown in the absence of selective pressure and those that are phenotypically unstable under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 286319      PMCID: PMC383253          DOI: 10.1073/pnas.76.3.1373

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

Authors:  S KIT; D R DUBBS; L J PIEKARSKI; T C HSU
Journal:  Exp Cell Res       Date:  1963-08       Impact factor: 3.905

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

4.  Mutations affecting adenine phosphoribosyl transferase activity in Chinese hamster cells.

Authors:  L A Chasin
Journal:  Cell       Date:  1974-05       Impact factor: 41.582

5.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

6.  Cotransfer of two linked human genes into cultured mouse cells.

Authors:  K Willecke; R Lange; A Krüger; T Reber
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

7.  Mutant alleles for hypoxanthine phosphoriboxyltransferase: codominant expression, complementation, and segregation in hybrid Chinese hamster cells.

Authors:  L A Chasin; G Urlaub
Journal:  Somatic Cell Genet       Date:  1976-09

8.  Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells.

Authors:  W F Flintoff; S V Davidson; L Siminovitch
Journal:  Somatic Cell Genet       Date:  1976-05

9.  Transformation of yeast.

Authors:  A Hinnen; J B Hicks; G R Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  Transfer of the human gene for hypoxanthine-guanine phosphoribosyltransferase via isolated human metaphase chromosomes into mouse L-cells.

Authors:  K Willecke; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

View more
  539 in total

1.  Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

Authors:  B H Spain; C J Larson; L S Shihabuddin; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.

Authors:  H Akari; S Arold; T Fukumori; T Okazaki; K Strebel; A Adachi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M Holgado-Madruga; I Royal; M A Naujokas; T M Fournier; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.

Authors:  T M Fournier; L Lamorte; C R Maroun; M Lupher; H Band; W Langdon; M Park
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

7.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein.

Authors:  A Beaton; P Palumbo; K I Berns
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

10.  Distinguishable promoter elements are involved in transcriptional activation by E1a and cyclic AMP.

Authors:  K A Lee; J S Fink; R H Goodman; M R Green
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.